(CURE) Direxion Daily Healthcare - Ratings and Ratios

The Direxion Daily Healthcare Bull 3X Shares (NYSE ARCA:CURE) is a leveraged ETF designed to provide 3X daily returns relative to the performance of its underlying index, which tracks domestic healthcare companies. The fund allocates at least 80% of its net assets to financial instruments delivering 3X exposure to the index. The index spans key healthcare subsectors, including pharmaceuticals, healthcare equipment, biotechnology, healthcare providers, and life sciences. As a non-diversified fund, it can concentrate investments in a smaller range of securities. For more information, visit http://www.direxionfunds.com.

3-Month Forecast: Based on the technical and fundamental data, CURE is expected to trade within a range of $110-$120 over the next three months. The funds price of $115.25 is currently above its 20-day SMA ($110.06) and 50-day SMA ($103.15) but slightly below its 200-day SMA ($116.71), suggesting near-term bullish momentum with potential resistance near $117. The ATR of 3.61 indicates moderate daily volatility, while the AUM of $177.65M reflects sufficient liquidity to support its trading strategy.